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A mammalian DNA repair enzyme that excises oxidatively
damaged guanines maps to a locus frequently lost in lung cancer
Rongzhen Lu, Huw M. Nash and Gregory L. Verdine
Background: Guanine residues in the genome are vulnerable to attack by free
radicals and reactive oxygen species. A major lesion thus produced, 8-oxoguanine
(OG), causes mutations by mis-pairing with adenine during replication. In bacteria
and budding yeast, OG is removed from the genome through the action of base-
excision DNA repair (BER) enzymes, which catalyze expulsion of the aberrant
base and excision of its sugar moiety from the DNA backbone. Although OG is
known to be produced in and cleansed from mammalian genomes, the enzymes
responsible for OG repair in these cells have remained elusive. 
Results: Here, we report the cloning and biochemical characterization of
mammalian BER enzymes that specifically target OG residues in DNA. These 8-
oxoguanine DNA glycosylases, hOgg1 (human) and mOgg1 (murine), are
homologous to each other and to yeast Ogg1. They also contain an active site
motif — the Helix–hairpin–Helix, Gly/Pro-rich–Asp motif — characteristic of a
superfamily of BER proteins with a similar core fold and active site geometry.
Both hOgg1 and mOgg1 exhibit exquisite selectivity for the base opposite OG in
DNA, operating with high efficiency only on OG base-paired to cytosine.
Furthermore, hOgg1 and mOgg1 are unable to process a panel of alternative
lesions, including 8-oxoadenine, yet bind with high affinity to synthetic abasic site
analogs. The proteins operate through a classical glycosylase/lyase catalytic
mechanism; mutation of a catalytically essential lysine residue results in loss of
catalytic potency but retention of binding to OG-containing oligonucleotides. The
hOGG1 gene is localized on the short arm of chromosome 3 (3p25/26) in a
region commonly deleted in cancers.
Conclusions: These results conclusively establish the existence and identity of an
8-oxoguanine DNA glycosylase/lyase in human and murine cells, completing the
triad of proteins that together protect mammals from the genotoxic effects of
guanine oxidation. The observation that at least one allele of hOGG1 is commonly
deleted in cancer cells suggests that such cells may possess a reduced capacity
to counter the mutagenic effects of reactive oxygen species, a deficiency that
could increase their overall genomic instability. This speculation is fueled by
recent observations that cells constitutively active for the Ras/Raf pathway
constitutively produce high levels of superoxide, a known generator of OG. 
Background
The reduction of molecular oxygen to water is central to
the process of energy utilization in cells. This four-
electron process proceeds stepwise through a series of
partially reduced intermediates, known collectively as
reactive oxygen species (ROS), which include superoxide
ion (O2•
–), hydrogen peroxide (H2O2) and hydroxyl radical
(HO•). ROS are not only generated as by-products of
metabolism, but have also been implicated as key
mediators of intracellular signal transduction pathways
[1–6]. Exogenous sources of ROS include ionizing radia-
tion, free radicals, singlet-oxygen sensitizer dyes and
redox-active organic molecules. Irrespective of their
source, ROS are potent genotoxins that attack DNA and
initiate the formation of oxidative lesions [7]. These ROS-
induced alterations in genome structure have been impli-
cated in a variety of pathophysiological processes,
especially in cancer and aging [8].
A lesion produced in great amounts and probably having
the most deleterious effects is 8-oxoguanine (OG, also
known as 8-hydroxyguanine) [9], which mis-pairs prefer-
entially with adenine during replication and thereby gives
rise to G:C to T:A transversion mutations [10]. Owing to
their persistent generation, relative abundance and
potent mutagenicity, OG residues are believed to repre-
sent a major source of spontaneous mutagenesis in all
aerobic cells [7]. 
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The mechanisms that confer resistance to guanine oxida-
tion in Escherichia coli have been studied extensively
[10–14]. This resistance pathway, known as the GO
system, comprises three component enzymes, MutM,
MutY and MutT. MutM (also known as Fpg) is a DNA
glycosylase/lyase that recognizes primary OG lesions in
DNA and catalyzes base excision and subsequent degrada-
tion of the sugar moiety so as to carve out the entire aber-
rant nucleoside from DNA. MutY is a monofunctional
DNA glycosylase that recognizes the product of OG mis-
replication — OG:A base-pairs — and catalyzes hydrolytic
excision of the inappropriate adenine base. The final com-
ponent of the resistance triad is MutT, which is not a DNA
repair enzyme, but rather a triphosphatase that acts to sani-
tize the nucleotide precursor pool by catalyzing the hydrol-
ysis of 8-oxo-dGTP to 8-oxo-dGMP and inorganic
pyrophosphate. Targeted disruption of the mutM and mutY
genes alone or in combination results in a spontaneous G:C
to T:A mutator phenotype under normal growth conditions
[11,15,16], whereas disruption of mutT affords a sponta-
neous A:T to C:G mutator phenotype [15]. Interestingly,
MutY actually increases the rate of A:T to C:G transver-
sions in mutT– bacteria [17]. These data are fully consistent
with the notion of a resistance system in which the individ-
ual components cooperate functionally. 
Whereas the bacterial GO system is now well understood,
the corresponding OG-resistance system in eukaryotic
cells has only recently yielded to study. Mammalian MutT
homologs have been cloned and functionally characterized
[18,19], and a likely human MutY cDNA has been
reported [20], but mammalian MutM homologs are
unknown. Two OG-specific repair activities have been
partially purified from human cells, one reportedly an
endonuclease and the other a glycosylase [21]. Two OG-
specific glycosylase/lyase activities have been detected in
the budding yeast Saccharomyces cerevisiae [22,23]; one of
these, yOgg1, has been cloned, overproduced and prelimi-
narily characterized [23,24]. Interestingly, even though
yOgg1 and MutM recognize the same substrates, OG and a
related ring-opened formamidopyrimidine (FAPy) adduct,
the yeast enzyme has no discernible sequence similarity to
MutM, and the two enzymes can be inferred to use an
altogether different catalytic machinery [23,25].
The amino acid sequence of yOgg1 contains a sequence
element known as the Helix–hairpin–Helix, Gly/Pro-
rich–Asp (HhH-G/PD) motif, which contains residues
essential for substrate recognition and catalysis, and which
defines yOgg1 as a member of an evolutionarily conserved
base-excision DNA repair (BER) protein superfamily [23].
X-ray crystal structures of two  members of the superfam-
ily have been reported to date, E. coli endonuclease III
[26] and AlkA [27]. Each of these represents a distinct
sub-class of the BER superfamily, glycosylase/lyases
(endo III) and monofunctional glycosylases (AlkA), which
differ in the mechanism by which they process the sub-
strate. Whereas monofunctional glycosylases simply dis-
place the aberrant base using water as a nucleophile,
glycosylase/lyases appear to use the e-NH2 group of a
lysine side-chain as the nucleophile, thereby resulting in
transient covalent attachment of the enzyme to its sub-
strate. Importantly, the ordinarily fleeting Schiff base
(imine) intermediate formed during the catalytic cycle can
be intercepted by borohydride [28], resulting in conver-
sion to an irreversibly linked glycosylase/lyase–DNA
complex. This ability to ‘tag’ the protein with its DNA
substrate allows whole cell extracts to be assayed for the
presence of particular repair activities, and the activities to
be isolated once identified. Borohydride trapping has
been used to isolate yOgg1 [23] and a bovine endonucle-
ase III homolog [29]. Here, we report the use of borohy-
dride trapping to identify and characterize yOgg1
homologs in human and murine cells.
Results
Identification of cDNAs encoding mammalian Ogg1
homologs
In an attempt to identify mammalian 8-oxoguanine glyco-
sylases, the amino acid sequence of yOgg1 [23,24] was
used to query the database of expressed sequence tags
(dbESTs) using the TBLASTN routine [30]. An EST
from one human cDNA clone, N55934 (Fig. 1a), was iden-
tified as encoding a potential translated sequence similar
to that of yOgg1. Another, overlapping human EST from
clone W04935 was identified by BLASTN alignment [30]
of the N55394 nucleotide sequence against the database.
Complete DNA sequencing of these clones revealed them
to be identical, with the exception that W04935 contained
an extension at its 5′ end of ~400 bp, a large internal dele-
tion (nucleotides 450–890), and a 17 bp insertion (after
nucleotide 948). The region of N55394 deleted in W04935
encodes an open reading frame (ORF) with stretches of
substantial sequence identity to yOgg1 (Fig. 1b, residues
143–279), including most or all of the enzyme active site
(see below); furthermore, in the upstream direction, this
yOgg1-homologous ORF continues uninterrupted to the
5′ end of N55394 and several hundred nucleotides further
into the 5′ extension of W04935 before reaching an
in-frame stop codon. Immediately downstream of the in-
frame stop codon are two potential initiation codons,
assigned as Met1 and Met11; initiation at the external site
(Met1) is expected under ordinary circumstances, but the
internal site (Met11) may also be used in some instances.
This analysis established the coding sequence of most of
the human Ogg1-homologous protein.
To determine whether the 17 nucleotide insertion in
W04935 comprises part of the protein coding sequence, we
generated predicted protein sequences that differed only in
whether they possessed the 17 nucleotide segment, and
found that inclusion led to a predicted 45.8 kDa protein
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(not shown in Fig. 1b), whereas exclusion led to a predicted
38.8 kDa protein (shown in Fig. 1b). As shown in Figure 2
and discussed in further detail below, the shorter protein
expressed from the cDNA lacking the 17 nucleotide inser-
tion (clone RL129) exhibited 8-oxoguanine DNA glycosy-
lase activity, but the longer protein expressed from the
cDNA with the insertion (RL143) failed to exhibit such
activity. Furthermore, the size of the shorter protein com-
pared favorably with that of the 8-oxoguanine DNA glyco-
sylase activity detected in whole-cell extracts (data not
shown). We also note the presence of a nuclear localization
signal (NLS) at the far carboxy-terminal end of the ORF
lacking the 17 nucleotide segment (Fig. 1b, green), which
is not present in the ORF containing the segment (not
shown in Fig. 1b). Thus, although we cannot exclude the
possibility that the longer ORF is expressed, we conclude
that it does not encode a functional 8-oxoguanine DNA
glycosylase. RL129 therefore contains the proper cDNA
encoding the human Ogg1 homolog (hOgg1).
The hOgg1 cDNA sequence encodes a predicted 345
amino acid protein with a molecular mass of 38 780 Da
and with 37% overall identity to the amino acid sequence
of yOgg1. The level of identity is particularly high over a
segment of the sequence known as the HhH-G/PD motif
(see above) [23]. In particular, the residue corresponding
to Asp268 is invariant amongst all BER proteins, whereas
that corresponding to Lys249 is invariant amongst the
glycosylase/lyase sub-class of BER enzymes.
Further database searching using the hOgg1 amino acid
sequence led to the identification of two murine cDNA
clones containing homologous ESTs, AA103654 and
W70899 (Fig. 1a). Sequencing of these two clones
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Figure 1
(a) Alignment of human and murine cDNA
clones sequenced and characterized in this
study. N55394 and W04935 are human EST
cDNAs, and AA103654 and W70899 are
murine EST cDNAs. RL129 (hOGG1) was
constructed by the ligating the 5′ end of
W04935 (nucleotides –56 to 366) to the 3′
end of N55394 (367–1291), and RL143 was
constructed by substituting the 3′ end of
RL129 by the 3′ end of W04935
(908–1291); see Materials and methods.
Nucleotide numbering is according to the
longest ORF for both mOGG1 and hOGG1.
(b) Amino acid alignment of the homologous
human, murine and yeast Ogg1 proteins
(hOgg1, mOgg1 and yOgg1, respectively).
Both hOgg1 and mOgg1 are 345 amino
acids in length, with predicted molecular
weights of 38 780 Da and 38 820 Da,
respectively. The amino acid sequences of the
predicted hOgg1 and mOgg1 proteins share
84% identity, and both share 37% identity to
yOgg1. All three proteins are members of the
HhH-G/PD superfamily of BER enzymes [23],
and the high degree of sequence
conservation suggests that they share a
common fold and active site configuration.
According to the current mechanistic
hypothesis [27], the carboxylate side chain of
Asp268 acts as a general base to activate the
e-NH2 group of Lys249 for nucleophilic
displacement of OG by mOgg1 and hOgg1.
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revealed them to be identical over the 1.45 Kb region they
share in common, and to contain a single ORF encoding a
protein of 345 amino acids, with a predicted molecular
mass of 38 820 Da (Fig. 1b). The amino acid sequence of
the predicted mOgg1 protein has 84% identity to that of
hOgg1 (Fig. 1b) and 37% identity to yOgg1. 
The mammalian Ogg1 homologs encode 8-oxoguanine
DNA glycosylases
To characterize biochemically the mammalian Ogg1
homologs, we used borohydride trapping assays
[23,28,31,32] on protein samples generated through in
vitro transcription/translation. This assay detects the
enzyme activity by intercepting an ordinarily transient
Schiff base (imine) intermediate formed between the
protein and its DNA substrate, and then reductively con-
verting it to an irreversibly linked protein–DNA
complex. As the formation of the Schiff base is absolutely
dependent upon the catalytic activity of the enzyme, the
trapping assay provides a stringent test for the function of
the enzyme. Moreover, since Schiff base formation is a
necessary step on the catalytic reaction pathway for both
cleavage of the glycosidic bond and subsequent scission
of the DNA backbone through conjugate elimination, the
observation of borohydride trapping per se establishes that
a BER enzyme operates via a glycosylase/lyase mecha-
nism (the monofunctional glycosylase class of BER
enzymes does not undergo borohydride trapping to any
significant extent). In the case of yOgg1, the substrate-
specificity in borohydride-trapping assays has been
shown to correlate closely with the specificity of DNA
strand cleavage [23]. 
In vitro transcription/translation of the human RL129
(hOGG1) and RL143 cDNAs yielded 35S-labeled protein
bands with apparent molecular weights of ~34 kDa (Fig. 2,
lane 4) and ~40 kDa (lane 7), respectively; these bands
were absent from control transcription/translation reactions
using the empty vector (lane 1). To determine which of
the human cDNA clones encodes a functional 8-oxogua-
nine DNA glycosylase/lyase, we carried out borohydride
trapping assays using duplex 25-mer and 50-mer DNA sub-
strates containing a single, centrally located OG:C base-pair
(Fig. 2). In the case of the RL129-encoded protein
(hOgg1), a single new band with retarded mobility was pro-
duced upon trapping, and only the ~34 kDa band was cor-
respondingly diminished in intensity, consistent with the
irreversible conversion of the RL129-encoded protein to a
higher molecular weight species. The apparent size of the
trapped species was increased by changing the DNA sub-
strate from a 25-mer to a 50-mer (Fig. 2, lanes 6 and 5,
respectively), thereby establishing conclusively that the
increase in mobility of hOgg1 upon trapping is due to its
being linked to DNA. As expected, trapping of unlabeled
hOgg1 with 32P-labeled OG:C 25-mer DNA gave a trapped
band of identical mobility to that shown in Figure 2, lane 6
(data not shown). The RL143-encoded protein exhibited
no detectable trapping activity with either OG substrate
(Fig. 2, compare lanes 7–9). Results similar to that
observed for RL129 (hOGG1) were obtained with the
murine Ogg1 cDNA (mOGG1) encoded by the clones
W70899 and AA103654 (Fig. 3). 
We next examined the preference of mOgg1 for the base
on the complementary strand opposite OG. As shown in
Figure 4a, significant levels of borohydride-trapped
protein–DNA complex were observed only with OG:C and
not with OG:A, OG:T, or OG:G. Similar results were
obtained for hOgg1, although the human protein exhibited
a slightly greater ability to process OG:T than did the
murine protein (data not shown). In contrast, although
yOgg1 traps (and repairs) OG:A and OG:G very poorly, the
yeast protein does act on OG:T with an efficiency
approaching that of OG:C [23]. Thus, the mammalian Ogg1
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Figure 2
Borohydride trapping of the proteins encoded by
human cDNAs RL129 and RL143 indicates that
RL129 is the coding sequence of the OG DNA
glycosylase/lyase hOgg1, and that the larger
protein produced by RL143 lacks OG
glycosylase/lyase activity. Both proteins were
35S-labeled by transcription/translation in vitro,
and were allowed to react with unlabeled 25-mer
or 50-mer OG:C DNA in the presence of NaBH4
so as to irreversibly trap active OG DNA
glycosylase/lyase to the DNA; control reactions
were performed with protein samples
transcribed/translated in vitro using the empty
vector (lanes 1–3). Reactions were analyzed by
SDS-PAGE. The DNA size-dependent difference
in mobility of the borohydride-trapped complex
formed with the RL129-encoded protein
(hOgg1) indicates that the complex contains
irreversibly linked DNA (compare lanes 5,6).
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homologs exhibit exquisite selectivity for the base opposite
OG, operating with great preference on OG:C only.
The ability of the mammalian Ogg1 homologs to
recognize substrates other than OG was analyzed by com-
petition trapping assays. A 32P-radiolabeled OG:C oligo-
nucleotide, mixed with a 100-fold excess of an unlabeled
competitor oligonucleotide, was incubated with mOgg1
(unlabeled, synthesized in vitro), and then borohydride
was added to effect the trapping reaction. Competitor
oligonucleotides that interact strongly with mOgg1 reduce
the intensity of the trapped protein–DNA complex. As
shown in Figure 4b, OG:C was an effective competitor
(lane 4), as was OG:T (lane 6). This interaction was spe-
cific, as neither the non-specific control G:C DNA (lane 2)
nor oligonucleotides having OG paired to A or G (lanes
3,5) competed effectively. The reduced specificity of
mOgg1 for OG:C versus OG:T in the competition assay, as
compared with the direct trapping assay (Fig. 4b) may
result from enzyme saturation by the relatively high con-
centrations of oligonucleotide used in the competition
assay. Alternatively, it is possible that the enzyme cat-
alyzes glycosidic bond cleavage more rapidly on the OG:C
substrate than on OG:T; this kinetic substrate selection,
which has been observed for other catalytic DNA-binding
proteins [31], would be detected more readily in direct
trapping assays than by competition. Importantly, mOgg1
appears incapable of binding the alternative oxidized
purine substrate 8-oxoadenine (OA:T, lane 7) or the alky-
lated purine N1,N6-ethenoadenine (eA:T, lane 8).
Using the competition trapping assay, we also examined the
ability of several synthetic inhibitors of DNA glycosylases
to bind mOgg1 tightly. The reduced abasic site (rAB)
binds with nanomolar affinity to yOgg1 and several other
DNA glycosylases (H.M.N. and G.L.V., unpublished
observations) [33], including the non-homologous bacterial
8-oxoguanine DNA glycosylase MutM [34]; it also com-
peted very effectively for mOgg1 (lane 9). The pyrrolidine
abasic site (Pyr), which binds DNA glycosylases with affini-
ties extending to the picomolar range [33,35], also com-
peted for mOgg1 efficiently (lane 10). The potential
inhibitor 8-oxo-2′-flouro-2′-deoxyguanosine (2′F-OG),
which differs from the normal substrate only in having the
2′-bH replaced by F (lane 11), produced no significant level
of competition; 2′F-OG competes poorly against trapping by
yOgg1 and MutM (H.M.N. and G.L.V., unpublished obser-
vations). Virtually identical trapping results were obtained
with in vitro synthesized hOgg1 (data not shown). Overall,
the trends observed in these competition trapping assays
with the mammalian Ogg1 homologs are similar to those
observed with yOgg1, fully consistent with the notion that
mOgg1 and hOgg1 are both structural and functional
homologs of yOgg1.
Probing the active site and mechanism of mammalian
Ogg1 using site-directed mutagenesis 
According to the current mechanistic understanding, the
catalytic nucleophile of BER superfamily glycosylase/
lyases is a conserved lysine residue within the HhH-G/PD
motif, which in the case of hOgg1/mOgg1 is amino acid
249 (Fig. 1b). This residue becomes linked irreversibly to
the DNA upon borohydride trapping. Consistent with this
notion, mutation of the corresponding lysine residue in
yOgg1 to glutamine (K241Q yOgg1) results in loss of gly-
cosylase/lyase activity and failure to undergo borohydride
trapping with OG-containing DNA, but retention of the
ability to recognize DNA containing abasic site analogs
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Figure 3
Borohydride trapping of the protein encoded by
murine cDNA W70899 indicates that it is the
coding sequence of the OG DNA
glycosylase/lyase mOgg1. The protein was 35S-
labeled by transcription/translation in vitro, and
was allowed to react with unlabeled 25-mer or
50-mer OG:C DNA in the presence of NaBH4 so
as to irreversibly trap active OG DNA
glycosylase/lyase to the DNA; control reactions
were performed with protein samples
transcribed/translated in vitro using the empty
vector (lanes 1–3). Reactions were analyzed by
SDS-PAGE. The DNA size-dependent difference
in mobility of the borohydride-trapped complex
formed with mOgg1 indicates that the complex
contains irreversibly linked DNA (compare lanes
5,6). The origin of the two minor protein bands of
greater size than mOgg1 in lanes 4–6 is unclear;
these do not undergo borohydride trapping. The
trapped mOgg1–DNA complexes appear as
closely spaced doublets, perhaps reflecting
some amount of DNA strand cleavage prior to
trapping. 
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[23]. To test this hypothesis with mOgg1, we constructed
the corresponding K249Q mOgg1 protein and tested its
ability to trap covalently and bind non-covalently to a
OG:C oligonucleotide (Fig. 5). Unlike wild-type mOgg1
(Fig. 5a, lane 4), the K249Q mutant mOgg1 failed to
undergo trapping (lane 6), but was fully capable of
forming a non-covalent complex with a radiolabeled OG:C
oligonucleotide (Fig. 5b, compare lanes 3,4). 
Chromosomal localization of hOGG1
The chromosomal localization of the hOGG1 gene was
determined by fluorescence in situ hybridization (FISH)
analysis, using the hOGG1 cDNA as a probe. Figure 6a
shows paired sister chromatids of chromosome 3, in which
a positive fluorescence signal can clearly be seen near the
tip of both short arms. Figure 6c presents the statistical
analysis for ten preparations analyzed by FISH, in which
the dots represent probe fluorescence in a particular band.
These data indicate that the hOGG1 gene is located in the
region near the junction of 3p25 and 3p26. 
Discussion
All cells that carry out aerobic metabolism suffer the oxi-
dation of guanine residues in DNA and in the nucleotide
precursor pool to 8-oxoguanine (OG). The tendency of OG
to mis-pair with A during replication creates a persistent
threat to the integrity of the genome. Whereas the multi-
enzyme (MutMYT) system responsible for purging OG
from the genome and nucleotide precursor pool of E. coli
has been extensively studied, the corresponding defense
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Figure 4
(a) The mOgg1 protein expressed in vitro and
the predominant OG DNA glycosylase/lyase in
murine (MEL) cells possess nearly identical
specificities for the base paired opposite OG,
and also possess similar apparent molecular
weights, as determined by borohydride
trapping with 32P-radiolabeled OG:N 25-mer
duplexes. The OG:N substrate preferences of
mOgg1 and the MEL activity are: OG:C >>
OG:T > OG:G ~ OG:A. Products of the
trapping reactions were analyzed by SDS-
PAGE. (b) mOgg1 possesses a high degree
of specificity for OG:C as a substrate.
Borohydride trapping of in vitro synthesized
mOgg1 with radiolabeled OG:C 25-mer DNA
in the presence of a 100-fold molar excess of
the 10 indicated unlabeled DNA duplexes
shows that OG:C (lane 4) and OG:T (lane 6)
are the most specific substrate competitors,
while DNA duplexes containing OG:A, OG:G,
OA:T or 1,N6edA:T are poor specific
competitors (lanes 3,5,7,8). Both the rAB site
DNA and the pyrrolidine DNA are specific
inhibitors (lanes 9,10), while 2’FOG DNA fails
to compete (lane 11).
 MEL   mOgg1     MEL  mOgg1      MEL  mOgg1      MEL  mOgg1    
°G:A    °G:C    °G:T  °G:GDNA:
Protein:
Trapped 
complex
Free DNA
1       2 3       4 5       6 7       8
(a)
(b)
 – G:C °G:A °G:C °G:G °G:T °A:T εA:T rAB Pyr  2'F°G
Substrate
Trapped 
complex
Free DNA
1 2 3 4 5 6 7 8 9 10 11
systems in eukaryotic cells have remained poorly charac-
terized. Here, we report the definitive identification and
molecular cloning of hOgg1 and mOgg1, homologous 8-
oxoguanine DNA glycosylases that presumably serve as
the cornerstone of a defense mechanism against oxidative
mutagenesis in human and murine cells.
The hOgg1 and mOgg1 ptoteins are highly homologous to
each other, and also exhibit a significant level of sequence
similarity to a recently identified 8-oxoguanine DNA
glycosylase in budding yeast cells, yOgg1 [23,24]. Like
yOgg1, mOgg1 and hOgg1 display a pronounced prefer-
ence for the identity of the base opposite OG. All three of
these eukaryotic 8-oxoguanine DNA glycosylases operate
with high efficiency on OG:C, consistent with the notion
that their primary function is to reverse the damage result-
ing from oxidation of normally base-paired G residues in
DNA, prior to replication. The mammalian and yeast
enzymes also are similar in that they act with poor effi-
ciency on OG:A and OG:G. The aversion to these particular
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Figure 5
(a) Borohydride trapping with the K249Q mutant of mOgg1 confirms
that Lys249 is essential for OG DNA glycosylase/lyase activity. Both
wild-type and K249Q mutant Ogg1 proteins (synthesized in vitro and
labeled with 35S) were allowed to react with unlabeled OG:C 25-mer
DNA, and the products of the reaction were analyzed by SDS-PAGE;
control reactions were performed with in vitro synthesized protein from
the empty vector (lanes 1,2). The absence of a higher molecular weight
species in lane 6 indicates that the K249Q mutant is unable to form the
Schiff base intermediate required for OG DNA glycosylase/lyase activity.
(b) Electrophoretic mobility shift assay (EMSA) of wild-type and K249Q
mutant mOgg1 proteins (synthesized in vitro) confirms that mutation of
the putative active site nucleophile, Lys249, does not affect the ability of
the protein to bind OG:C DNA non-covalently. Wild-type and K249Q
mutant mOgg1 proteins were incubated with 32P-radiolabeled OG:C
25-mer DNA at room temperature for 10 min before analysis by 8%
native acrylamide gel electrophoresis at 4°C (lanes 3 and 4,
respectively). Control reactions included 32P-radiolabeled OG:C 25-mer
DNA alone (lane 1) or incubation of 32P-radiolabeled OG:C 25-mer
DNA with in vitro synthesized protein from the empty vector (lane 2).
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Figure 6
FISH analysis of hOGG1. (a) The paired fluorescent signals obtained
by specific hybridization of the hOGG1 cDNA probe to the tips of the
paired sister chromatids of chromosome 3. (b) The DAPI banding
pattern of the chromosomes in (a). (c) The chromosomal localization of
hOGG1 is 3p25/26. Data from 10 photos, one of which is shown in
(a), are summarized in this diagram, with each bullet representing an
independent assignment. 
substrates, especially OG:A, enables the enzyme to avoid
catalyzing error-prone repair of misreplicated OG residues,
which would thereby facilitate the overall mutagenic trans-
version of G:C to T:A or C:G, respectively. They differ,
however, in that yOgg1 processes OG:T almost as well as
OG:C, whereas hOgg1 and mOgg1 do not process OG:T
efficiently. Like the yeast enzyme, recombinant hOgg1
expressed in E. coli preferentially cleaves OG opposite C
by a b-elimination mechanism, and does not possess an
efficient d-lyase activity (H.M.N and G.L.V, unpublished
observations). Also, like yOgg1, mOgg1 and hOgg1 fail to
undergo borohydride-dependent trapping to any of the
alternative substrates we have tested thus far, and are
potently inhibited by the abasic site analog rAB [34] and
the transition state mimetic Pyr [35], but are not inhibited
by the fluorosugar-containing substrate 2′F-OG (T. Kawate
and G.L.V., unpublished observations). Taken together,
these data conclusively establish that hOgg1 and mOgg1
are functional homologs of yOgg1 in mammalian cells. 
The 37% sequence identity between yOgg1 and the mam-
malian proteins indicates that they are also structural
homologs. Clearly discernible in the amino acid sequence
of the Ogg1 proteins is a ~30 amino acid motif known as the
HhH-G/PD motif [23,36], which comprises the active site
region of a superfamily of BER enzymes conserved
throughout evolution [23] (Fig. 1b). Although most
members of this BER superfamily exhibit little or no
sequence similarity outside the HhH-G/PD motif, two such
seemingly divergent enzymes, E. coli endonuclease III [26]
and AlkA [27], have been shown through crystallographic
studies to contain a remarkably conserved core domain
structure that includes the enzyme active site. A similar
core domain structure has also been discovered in the 5′
deoxyribosephosphate DNA repair domain of human DNA
polymerase b [37], and may also be present in a variety of
non-repair-related proteins that bind DNA [36,38]. 
BER enzymes can be grouped into two major sub-classes:
those that catalyze only the hydrolysis of the glycosidic
bond (monofunctional glycosylases), and those that cat-
alyze base-excision followed by degradation of the result-
ing abasic site (glycosylase/lyase). Both sub-classes are
represented within the BER superfamily, and both are
characterized by the presence of an invariant aspartate
residue at the carboxy-terminal end of the HhH-G/PD
motif (residue 268 in mOgg1/hOgg1). This aspartate
residue plays a key role in catalysis, presumably serving as
a general base to deprotonate the nucleophile that directly
displaces the aberrant base from its sugar moiety [27]. The
only other residue strongly implicated through biochemi-
cal studies as playing a key catalytic role is the lysine
located at position 249 in mOgg1/hOgg1. This residue is
invariant in glycosylase/lyases, but is lacking altogether in
monofunctional glycosylases, suggesting that it represents
a point of mechanistic bifurcation between the two classes
of BER enzymes. Indeed, Lys249 and its counterpart in
other enzymes is believed to function as the nucleophile
that attacks the glycosidic bond and subsequently cat-
alyzes DNA backbone cleavage through Schiff base chem-
istry. On the other hand, in monofunctional glycosylases,
the attacking nucleophile is almost certainly an activated
water molecule [27]. Here, we report that the K249Q
mutant mOgg1 protein, which cannot form a Schiff base,
fails to trap a OG:C-containing duplex, yet retains the
ability to bind this DNA non-covalently (Fig. 5). These
data establish that mOgg1 and hOgg1, like yOgg1, are
8-oxoguanine DNA glycosylase/lyases. 
The identity of hOgg1 as a member of the BER superfam-
ily provides a clue to the dysfunction we observed for the
isoform containing the carboxy-terminal 17 nucleotide
insertion (ORF encoded on RL143). The presence of this
insert causes a shift in the reading frame, beginning at
residue 316 and continuing on to the carboxyl terminus of
the alternative protein. The region comprising residues
~310–320 of hOgg1/mOgg1, the carboxy-terminal end of
which is directly affected by the insertion-directed frame-
shift, exhibits weak but notable sequence similarity to an
a-helix in AlkA (a-M); amino acid side-chains at the far
carboxy-terminal end of this helix project directly into the
AlkA active site immediately alongside the key catalytic
aspartate residue (W272 and Y273 in AlkA; refer to Figs 4
and 5c in [27]), where they are virtually certain to contact
directly the substrate base. We propose that alteration of
this key helix in the frameshifted RL143 cDNA causes a
loss of 8-oxoguanine glycosylase activity. The present
analysis furthermore suggests that residues in the 310–320
stretch of mammalian Ogg1s, all but one of which are
invariant in yOgg1, contact the OG substrate base directly
when bound in the enzyme active site. Whether the
RL143-encoded protein has acquired a new function as
the result of changes in its active site functionality, as
seems possible if not probable, remains to be determined. 
Curiously, the Ogg1 proteins share no detectable sequence
similarity with MutM, the bacterial 8-oxoguanine DNA
glycosylase protein. MutM contains no sequence that even
vaguely matches the HhH-G/PD consensus motif, suggest-
ing it contains an altogether different active site and fold
from the Ogg1 proteins and all other members of the BER
superfamily. This hypothesis is strongly supported by the
fact that MutM uses its amino-terminal proline residue as
the attacking nucleophile [25], whereas BER superfamily
glycoylase/lyases use an internal lysine residue. Moreover,
the substrate specificity of MutM is distinctly different
from that of the Ogg1 proteins. On the basis of these con-
siderations, we can rule out with reasonable certainty that
MutM is structurally or evolutionarily related to yeast or
mammalian Ogg1 proteins; it is most appropriate, there-
fore, to designate hOgg1 and mOgg1 according to their
structural and functional similarity to yOgg1. Interestingly,
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MutM may not have altogether evaded progression to the
eukaryotic lineage: a homolog of MutM has been identi-
fied in the plant Arabidopsis thaliana (H.M.N., unpublished
observations; Genbank z18192), but not biochemically
characterized. 
The cloning of a mammalian Ogg1 completes the triad of
proteins that together protect mammalian cells from the
genotoxic effects of OG. A human homolog of MutT
(hMutT), a triphosphatase that cleanses the precursor pool
of 8-oxo-dGTP by catalyzing its conversion to 8-oxo-
dGMP and inorganic pyrophosphate, has been reported
[18]. Database searching led to the identification of a
cDNA having substantial sequence similarity to bacterial
MutY, a monofunctional glycosylase of the BER superfam-
ily, which catalyzes the hydrolysis of adenine residues mis-
paired to OG [20]. A human protein involved in a parallel
BER pathway specific for oxidized pyrimidines has been
cloned and characterized [39,40]. The importance of the
Ogg1 proteins in preventing spontaneous oxidative muta-
genesis has been demonstrated in yeast cells: targeted dis-
ruption of the yOGG1 gene results in a 30-fold elevation of
the rate of G:C to T:A transversions relative to yOGG1+
cells (H.M.N and G.L.V, unpublished observations). 
Chromosomal localization of hOGG1
Our FISH mapping results establish that hOGG1 gene is
located on the distal end of the short arm of chromosome 3
(3p25/26), a region that has aroused much attention within
the cancer biology community. Nearly 100% of cells
derived from small cell lung cancers — approximately one
third of all lung cancers — possess allelic deletions of most
of the short arm of chromosome 3 (3p) [41–45]. More than
half of all non-small cell lung cancers are also character-
ized by the loss of heterozygosity at chromosome 3
[43–48]. Importantly, the majority of lung cancers have
arisen in individuals with a history of cigarette smoking.
The combustion of tobacco material results in the produc-
tion of ROS, species that are particularly effective at gen-
erating OG residues in DNA; inhalation of tobacco smoke
results in the delivery of high concentrations of ROS to
the lung, thereby increasing the oxidative burden on these
tissues. Lung cells that have lost one allele of hOGG1
through a chromosomal deletion event may thus have a
reduced capacity to counter the mutagenic burden
imposed by massive influxes of exogenous ROS. This in
turn may accelerate the acquisition of other mutations that
contribute to the overall process of cell transformation. 
Oxidative stress can also be imposed through endogenous
processes in cells. Rapidly dividing cells have a high
requirement for energy production through mitochondrial
respiration, an aerobic process that liberates ROS into the
cell [7]. Most intriguing in this regard is the finding that
constitutive activation of the Ras/Raf signaling pathway
causes a dramatic increase in the intracellular concentration
of superoxide (O2•
–), an OG-generator that is proposed to
act as a downstream mediator of this mitogenic signal in
cells [1]. Deletions and other aberrations affecting 3p have
been observed in a variety of tumors other than the lung,
especially sporadic cancers of the kidney and breast [49],
strongly suggesting the existence of one or more tumor
suppressor genes on 3p. Two such candidate tumor sup-
pressor genes have been identified, FHIT (3p14) [50] and
VHL (3p25) [51]. In light of the recent discoveries that
functional disruption of mismatched repair genes con-
tributes to genetic instability and cancer [52–54], the
present findings raise the prospect that hOGG1 may func-
tion as a human tumor suppressor gene, and partial or total
loss of the mammalian Ogg1 proteins may predispose cells
toward oncogenic transformation. 
Materials and methods
EST clones and DNA sequencing
Murine and human clones containing Ogg1 ESTs were products of the
IMAGE consortium sequencing effort, and were purchased from
Genome Systems. Murine and human OGG1 sequences were
sequenced on both strands with Sequenase version 2.0 (USB) as per
the supplier’s instructions using denatured plasmid DNA as the template.
In situ hybridization and FISH detection
FISH mapping was performed by See DNA Biotech. A 1.2 kb hOGG1
cDNA probe was biotinylated with biotin-14-dATP using the BRL
BioNick labeling kit (15°C, 1 h) [55]. The procedure for FISH detection
was performed according to published procedures [55,56]. Briefly,
slides were prepared by standard procedures with cultured human lym-
phocytes and baked at 55°C for 1 h. After RNase treatment, the slides
were denatured in 70% formamide in 2× SSC for 2 min at 70°C, fol-
lowed by dehydration with ethanol. Probes were denatured at 75 °C for
5 min in a hybridization mix consisting of 50% formamide and 10%
dextran sulfate. Probes were loaded on the denatured chromosomal
slides, and after overnight hybridization, the slides were washed, ampli-
fied and detected. FISH signals and the DAPI banding patterns were
recorded with separate photographs, and the chromosomal localization
was achieved by superimposing the FISH signals with the DAPI
banded chromosomes [57]. Under the conditions used, the hybridiza-
tion efficiency was approximately 68% (among 100 checked mitotic
figures, 68 of them showed signals on one pair of chromosomes). The
detailed chromosomal location, 3p25, was determined from the
summary of 10 photos. No additional loci were observed.
In vitro transcription/translation of mOgg1 and hOgg1 proteins
The coding sequences of the human and murine OGG1 genes were
subcloned into the pT7T3D expression vector (Pharmacia), and the T7
promoter was used to express the proteins in vitro using the T7 TNT
Coupled Reticulocyte Lysate system (Promega) as per the supplier’s
instructions. The mOGG1 coding sequence (W70899) was inserted
into pT7T3D as an Nhe I/Not I fragment, with the NheI site occurring
naturally in the 5′ UTR at position –8 and the NotI site originating from
the EST carboxy-terminal primer. The hOGG1 coding sequence
(RL129) was assembled in pT7T3D by ligating the amino terminus of
W04935 (an EcoRI/PflMI fragment) to the carboxyl terminus of N55394
(a PflMI/NotI fragment); the PflMI site occurs naturally at position 366 of
the coding sequence, while the EcoRI and NotI sites originate from the
EST primers. The larger, alternately-spliced, hOGG1 coding sequence
(RL143) was obtained by substituting the carboxy-terminal BspEI/NotI
fragment of RL129 with the BspEI/NotI fragment of W04935; the BspEI
site occurs naturally at position 908 of the coding sequence.
Oligonucleotide duplex substrates/competitors:
All oligonucleotides were synthesized by b-cyanoethyl solid-phase chem-
istry on a 1 mmole scale using an ABI model 392 DNA synthesizer, and
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were purified by 20% denaturing PAGE. Full-length DNA was eluted from
the acrylamide gel by crushing and soaking in 1 M triethylammonium
bicarbonate, pH 7, followed by C18 Sep-Pak concentration/desalting.
Concentrations were determined by A260 quantitation, and radiolabeling
reactions were performed with T4 polynucleotide kinase (New England
Biolabs) and g-[32P]ATP. Duplexes were prepared by annealing with a 50-
fold molar excess of the complementary strand in 1× TE/100 mM NaCl.
The radiolabeled strand of each duplex is the top strand as shown below.
1 8-oxodG:dA 5′ GGA TAG TGT CCA oG GTT ACT CGA AGC 3′
3′ CCT ATC ACA GGT A CAA TGA GCT TCG 5′
2 8-oxodG:dC 5′ GGA TAG TGT CCA oG GTT ACT CGA AGC 3′
25-mer 3′ CCT ATC ACA GGT C CAA TGA GCT TCG 5′
3 8-oxodG:dG 5′ GGA TAG TGT CCA oG GTT ACT CGA AGC 3′
3′ CCT ATC ACA GGT G CAA TGA GCT TCG 5′
4 8-oxodG:T 5′ GGA TAG TGT CCA oG GTT ACT CGA AGC 3′
3′ CCT ATC ACA GGT T CAA TGA GCT TCG 5′
5 8-oxodA:T 5′ GGA TAG TGT CCA oA GTT ACT CGA AGC 3′
3′ CCT ATC ACA GGT T CAA TGA GCT TCG 5′
6 1,N6edA:T 5′ GGA TAG TGT CCA eA GTT ACT CGA AGC 3′
3′ CCT ATC ACA GGT T CAA TGA GCT TCG 5′
7 dG:dC 5′ GTG AAC CTG AGC G TAG CTC AGT AAC 3′
3′ CAC TTG GAC TCG C ATC GAG TCA TTG 5′
8 rAB:dC 5′ GTG AAC CTG AGCrAB TAG CTC AGT AAC 3′
3′ CAC TTG GAC TCG C ATC GAG TCA TTG 5′
9 pyrrolidine: 5′ GGA TAG TGT CCA Pyr GTT ACT CGA AGC 3′
3′ CCT ATC ACA GGT T CAA TGA GCT TCG 5′
10 8-oxodG:dC 5′ GGC AAG TCT GAT GGA TAG TGT CCA oG 3′->
50-mer 3′ CCG TTC AGA CTA CCT ATC ACA GGT   C 5’->
-> 5′ GTT ACT CGA AGC AGT TCG AAC TGG 3′
-> 3′ CAA TGA GCT TCG TCA AGC TTG ACC 5′
Phosphoramidites of 8-oxo-dG [58], 8-oxo-dA [59], 1,N6edA [60], and
Pyr [35] monomers were synthesized according to published proce-
dures. The reduced abasic site (rAB) phosphoramidite was synthesized
by an unpublished procedure (H.M.N., J-Y. Ortholand and G.L.V.,
unpublished results).
DNA trapping assays with NaBH4
DNA trapping reactions were performed in a 25 ml volume in siliconized
microcentrifuge tubes at 37°C. The final concentrations in all reactions
were: 50 mM Tris, pH 7.5, 2 mM EDTA, 50 mM NaBH4, and 1 nM 32P-
radiolabeled OG:N 25-mer oligonucleotide duplexes 1–4. 2 ml of in vitro
transcribed/translated mOGG1 or hOGG1 was added to the trapping
reaction, and the reaction was incubated for 30 min (37°C) before termi-
nation with 1× SDS loading dye at 95°C for 5 min. Mammalian cell
lysate reactions contained 3 ml of cell extract and were incubated for
30 min (37°C) before termination in 1× SDS loading buffer at 95°C for
5 min. Competition trapping reactions were performed by a 10 min,
room temperature, preincubation of the in vitro transcribed/translated
mOgg1 protein with a 100-fold molar excess of unlabeled duplex com-
petitor, followed by the addition of the 32P-radiolabeled OG:C duplex 2
and NaBH4. The reactions were continued for 15 min at 37°C before
termination in 1× SDS loading dye at 95°C for 5 min. 15 ml of each ter-
minated DNA trapping reaction was loaded on 0.75 mm, 12% 37.5:1
acrylamide:bis-acrylamide, 0.1% SDS, SDS-PAGE gels. Gels were run
at a constant 25 mA for 3 h, and were fixed for 15 min at room tempera-
ture in 10% methanol/10% acetic acid. Fixed gels were dried for 1.5 h
and exposed to film (Kodak BioMax MR) and to a phosphorimaging
plate (Fuji BAS1000). The gel figures presented herein were initially
obtained as autoradiograms, scanned using a LACIE Silverscanner III
digital scanner, then imported into Adobe Photoshop 3.0 for captioning.
Relative trapping efficiencies were quantified by phosphorimager quanti-
tation. 14C molecular weight markers were from Life Technologies.
Electrophoretic mobility shift assays (EMSA)
Gel shift assays were performed with 3ml of in vitro transcribed mOGG1
protein and 1 nM 32P-radiolabeled OG:C oligonucleotide duplex 2 in a
20 ml binding reaction containing 50 mM tris, pH 8, 2 mM EDTA, 6%
glycerol and 0.05 mg ml–1 plasmid DNA. Binding reactions were incu-
bated at room temperature for 10 min before loading on a pre-run 8%
0.5× TBE acrylamide gel (37.5:1, Protogel, National Diagnostics). Gels
were run at 250 volts for 2.5 h at 4°C, then dried and exposed to film
(Kodak BioMax MR) and to a phosphorimaging plate (Fuji BAS1000).
The gel figures presented herein were initially obtained as autoradi-
ograms, scanned using a LACIE Silverscanner III digital scanner, then
imported into Adobe Photoshop 3.0 for captioning.
Site-directed mutagenesis of mOGG1
Lysine 249 of the mOgg1 protein was mutated to glutamine 249 by
replacing the wild-type NarI/BspEI fragment of mOGG1 with a PCR-
generated cassette bearing the AAG→CAG sequence change. The
sequences of the two PCR primers are shown below, with the restric-
tion sites in bold, and the K249Q mutation underlined:
NarI: 5′-TG CCC GGG GTG GGC GCC CAG GTG GC-3′
BspEI: 5′-CCA CAG ATT CCG GAA AAA GTT TCC-3′
The mutagenesis cassette was PCR amplified with Deep Vent DNA
polymerase (New England Biolabs), digested with NarI and BspEI, and
ligated into the NarI/BspEI-digested mOGG1/pT7T3D in vitro expres-
sion construct. The presence of the K249Q mutation and the absence
of any other undesired mutations was confirmed by DNA sequencing.
Acknowledgements
This research was supported by a grant from the National Institute of
General Medical Sciences (GM51330). We thank John Minna and Eric
Biesterveld for discussions and provision of human cell lines, Phil Familetti
and Donna Stremlo of Hoffmann-LaRoche for MEL cells, Yong-Ping Wang
for providing murine organs, and Pei Zhou, Steve Bruner and Li Jing Sun for
assistance with graphics.
References
1. Irani K, Xia Y, Zweier JL, Solott SJ, Der CJ, Fearon ER, et al.: Mitogenic
signaling mediated by oxidants in Ras-transformed fibroblasts.
Science 1997, 275:1649–1652.
2. Sundaresan M, Yu X-Z, Ferrans VJ, Irani K, Finkel T: Requirement for
generation of H2O2 for platelet-derived growth factor signal
transduction. Science 1996, 270:296–299.
3. Ohba M, Shibanuma M, Kuroki T, Nose K: Production of hydrogen
peroxide by transforming growth factor-b1 and its involvement in
induction of egr-1 in mouse osteoblast cells. J Cell Biol 1994,
126:1079–1088.
4. Lo YYC, Wong JMS, Cruz TF: Reactive oxygen species mediate
cytokine gene activation of c-Jun NH2-terminal kinases. J Biol Chem
1996, 271:15703–15707.
5. Los M, Schenk H, Hexel K, Baeuerle PA, Droge W, Schultze-Osthoff K:
IL-2 gene expression and NF-kB activation through CD28 requires
reactive oxygen production by 5-lipoxygenase. EMBO J 1995,
14:3731–3740.
6. Schmidt KN, Amstad P, Cerutti P, Baeuerle PA: Identification of
hydrogen peroxide as the relevant messenger inthe activation
pathway of transcriptionfactos NF-kB. Adv Exp Med Biol 1996,
387:63–68.
7. Friedberg EC, Walker GC, Siede W: DNA Repair and Mutagenesis,
Washington D.C.: ASM Press; 1995.
8. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants and the
degenerative diseases of ageing. Proc Natl Acad Sci USA 1993,
90:7915–7922.
9. Kasai H, Nishimura S: Formation of 8-hydroxydeoxyguanosine in
DNA by oxygen radicals and its biological significance. In Oxidative
Stress: Oxidants and Antioxidants. Edited by Sies H. London: Academic
Press; 1991:99–116.
10. Grollman AP, Moriya M: Mutagenesis by 8-oxoguanine: An enemy
within. Trends Genet. 1993, 9:246–249.
11. Michaels ML, Cruz C, Grollman AP, Miller JH: Evidence that MutY and
MutM combine to prevent mutations by an oxidatively damaged form
of guanine in DNA. Proc Natl Acad Sci USA 1992, 89:7022–7025.
12. Michaels ML, Tchou J, Grollman AP, Miller JH: A repair system for 8-
oxo-7,8-dihydrodeoxyguanine. Biochemistry 1992, 31:10964–10968.
13. Michaels ML, Miller JH: The GO system protects organisms from the
mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-
dihydro-8-oxoguanine). J Bacteriol 1992, 174:6321–6325.
14. Maki H, Sekiguchi M: MutT protein specifically hydrolyzes a potent
mutagenic substrate for DNA synthesis. Nature 1992, 355:273–275.
15. Tajiri T, Maki H, Sekiguchi M: Functional cooperation of MutT, MutM
and MutY proteins in preventing mutations caused by spontaneous
oxidation of guanine nucleotide in Escherichia coli. Mutat Res DNA
Repair 1995, 336:257–267.
406 Current Biology, Vol 7 No 6
16. Duwat P, de Oliveira R, Ehrlich SD, Boiteux S: Repair of oxidative DNA
damage in gram-positive bacteria: the Lactococcus lactis Fpg
protein. Microbiology 1995, 141:411–417.
17. Vidmar JJ, Cupples CG: MutY repair is mutagenic in mutT+ strains of
Escherichia coli. Can J Microbiol 1993, 39:892-894.
18. Sakumi K, Furuichi M, Tsuzuki T, Kakuma T, Kawabata S, Maki H,
Sekiguchi M: Cloning and expression of cDNA for a human enzyme
that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA
synthesis. J Biol Chem 1993, 268:23524–23530.
19. Cai JP, Kakuma T, Sekiguchi M: cDNA and genomic sequences for rat
8-oxo-dGTPase that prevents occurrence of spontaneous mutations
due to oxidation of guanine nucleotides. Carcinogenesis 1995,
16:2343–2350.
20. Slupska MM, Baikalov C, Luther WM, Chiang JH, Wei YF, Miller JH:
Cloning and sequencing a human homolog (hMYH) of the
Escherichia coli mutY gene whose function is required for the repair
of oxidative DNA damage. J Bacteriol 1996, 178:3885–3892.
21. Bessho T, Tano K, Kasai H, Ohtsuka E, Nishimura S: Evidence for two
DNA repair enzymes for 8-hydroxyguanine (7,8-dihydro-8-
oxoguanine) in human cells. J Biol Chem 1993, 268:19416–19421.
22. de Oliveira R, van der Kamp PA, Thomas D, Geiger A, Nehls P, Boiteux S:
Formamidine DNA glycosylase in the yeast Saccharomyces
cerevisiae. Nucleic Acids Res 1994, 22:3760–3764.
23. Nash HM, Bruner SD, Schärer OD, Kawate T, Addona TA, Sponner E,
Lane WS, Verdine GL: Cloning of a yeast 8-oxoguanine DNA
glycosylase reveals the existence of a base-excision DNA-repair
protein superfamily. Curr Biol 1996, 6:968–980.
24. van der Kemp PA, Thomas D, Barbey R, de Oliveira R, Boiteux S:
Cloning and expression in Escherichia coli of the OGG1 gene of
Saccharomyces cerevisiae, which codes for a DNA glycosylase that
excises 7,8-dihydro,8-oxoguanine and 2,6-diamino-4-hydroxy-5-N-
methylformamidopyramidine. Proc Natl Acad Sci USA 1996,
93:5197–5202.
25. Zharkov DO, Rieger RA, Iden CR, Grollman AP: NH2-terminal proline
acts as a nucleophile in the glycosylase/AP-lyase reaction catalyzed
by Escherichia coli formamidopyrimidine-DNA glycosylase (Fpg)
protein. J Biol Chem 1997, 272:5335–5341.
26. Kuo C-F, McRee DE, Fisher CL, O’Handley SF, Cunningham RP, Tainer
JA: Atomic structure of the DNA repair [4Fe-4S] enzyme
endonuclease III. Science 1992, 258:434–440.
27. Labahn J, Scharer OD, Long A, Ezaz-Nikpay K, Verdine GL, Ellenberger
TE: Structural basis for the excision repair of alkylation-damaged
DNA. Cell 1996, 86:321–329.
28. Dodson ML, Schrock RD,III, Lloyd RS: Evidence for an imino
intermediate in the T4 endonuclease V reaction. Biochemistry 1993,
32:8284–8290.
29. Hilbert TP, Boorstein RJ, Kung HC, Bolton PH, Xing D, Cunningham RP,
Teebor GW: Purification of a mammalian homolog of Escherichia
coli endonuclease III: identification of a bovine pyrimidine hydrate-
thymine glycol DNA-glycosylase/AP Lyase by irreversible cross
linking to a thymine glycol-containing oligodeoxynucleotide.
Biochemistry 1996, 35:2505–2511.
30. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local
alignment search tool. J Mol Biol 1990, 215:403–410.
31. Sun B, Latham KA, Dodson ML, Lloyd RS: Studies on the catalytic
mechanism of five DNA glycosylases. Probing for enzyme–DNA
imino intermediates. J Biol Chem 1995, 270:19501–19508.
32. Tchou J, Grollman AP: The catalytic mechanism of Fpg protein.
Evidence for a Schiff base intermediate and amino terminus
localization of the catalytic site. J Biol Chem 1995, 270:11671–11677.
33. McCullough AK, Schärer OD, Verdine GL, Lloyd RS: Structural
determinants for specific recognition by T4 endonuclease V. J Biol
Chem 1996, 271:32147–32152.
34. Castaing B, Boiteux S, Zelwer C: DNA containing a chemically
reduced apurinic site is a high affinity ligand for the E. coli
formamidopyrimidine-DNA glycosylase. Nucleic Acids Res 1992,
20:389–394.
35. Schärer OD, Ortholand J-Y, Ganesan A, Ezaz-Nikpay K, Verdine GL:
Specific binding of the DNA repair enzyme AlkA to a pyrrolidine-
based inhibitor. J Am Chem Soc 1995, 117:6623–6624.
36. Thayer MM, Ahern H, Xing DX, Cunningham RP, Tainer JA: Novel DNA
binding motifs in the DNA repair enzyme endonuclease III crystal
structure. EMBO J 1995, 14:4108–4120.
37. Pelletier H, Sawaya MR, Kumar A, Wilson SH, Kraut J: Structures of
ternary complexes of rat DNA polymerase beta, a DNA template-
primer, and ddCTP. Science 1994, 264:1891–1903.
38. Doherty AJ, Serpell LC, Ponting CP: The Helix-hairpin-Helix DNA-
binding motif: a structural basis for non-sequence-specific
recognition of DNA. Nucleic Acids Res 1996, 24:2488–2497.
39. Aspinwall R, Rothwell DG, Roldan-Arjona T, Anselmino C, Ward C,
Cheadle JP, et al.: Cloning and characterization of a functional
human homolog of Escherichia coli endonclease III. Proc Natl Acad
Sci USA 1997, 94:109–114.
40. Hilbert TP, Chaung W, Boorstein RJ, Cunningham RP, Teebor GW:
Cloning and expression of the cDNA encoding the human
homologue of the DNA repair enzyme, Escherichia coli
endonuclease III. J Biol Chem 1997, 272:6733–6740.
41. Kok H, Osinga J, Carrit B, Davis MB, van der Veen AY, Landsvater RM,
et al.: Deletion of a DNA sequence at the chromosomal region 3p21
in all major types of lung cancer. Nature 1987, 330:578–581.
42. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY: Loss of
heterozygosity of chromosome 3 markers in small-cell lung cancer.
Nature 1987, 329:451–454.
43. Rabbitts P, Bergh J, Douglas J, Collins F, Waters J: A submicroscopic
homozygous deletion at the D3S3 locus in a cell line isolated from a
small cell lung carcinoma. Genes Chromosomes Cancer 1990,
2:231–238.
44. Yokota A, Wada M, Shimosato Y, Terada M, Sugimura T: Loss of
heterozygosity on chromosomes 3, 13, 17 in small cell carcinoma
and on chromosome 3 in adenocarcinoma of the lung. Proc Natl
Acad Sci USA 1987, 84:9252–9256.
45. Brauch H, Johnson B, Hovis J, Yano T, Gadzar A, Pettengil O, et al.:
Molecular analysis of the short arm of chromosome 3 in small-cell
and non-small cell carcinoma of the lung. N Engl J Med 1987,
317:1109–1113.
46. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, et al.:
Three distinct regions involved in 3p deletions in human lung
cancer. Oncogene 1992, 7:445–449.
47. Horio Y, Takahashi T, Kuroishi T, Hibi K, Suyama M, Niimi T, et al.:
Prognostic significance of p53 mutations and 3p deletions in primary
resected non-small cell lung cancer. Cancer Res 1993, 53:1–4.
48. Yokohama S, Yamakawa K, Tsuchiya E, Murata M, Sakiyama S,
Nakamura Y: Deletion mapping on the srort arm of chromosome 3 in
squamous cell carcinoma and adenocarcinoma of the lung. Cancer
Res 1992, 52:873–877.
49. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS: Loss of heterozygosity
in normal tissue adjacent to breast carcinomas. Science 1997,
274:2057–2059.
50. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, et al.:
The FHIT gene is abnormal in lung cancer. Cell 1996, 85:17–26.
51. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al.: Identification
of the von Hippel-Lindau disease tumor suppressor gene. Science
1993, 260:1317–1320.
52. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC,
Vogelstein B: Mutation of a mutL homolog in hereditary colon
cancer. Science 1994, 363:1625–1629.
53. Leach FS, Nicloaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et
al.: Mutations of a mutS homolog in hereditary nonpolyposis colon
cancer. Cell 1993, 75:1215–1225.
54. Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C,
Palombo F, et al.: Mutations of GTBP in genetically unstable cells.
Science 1995, 268:1915–1917.
55. Heng HHQ, Squire J, Tsui L-C: High resolution mapping of
mammalian genes by in situ hybridization to free chromatin. Proc
Natl Acad Sci USA 1992, 89:9509–9513.
56. Heng HHQ, Tsui L-C: Modes of DAPI banding and simultaneous in
situ hybridization. Chromosoma 1993, 102:325–332.
57. Heng HHQ, Tsui L-C: FISH detection on DAPI banded chromosomes.
In Methods in Molecular Biology: In situ Hybridization Protocols. Edited
by Choo KHA. Clifton, NJ: Humana Press; 1994:35–49.
58. Roelen HCPF, Saris CP, Brugghe HF, van den Elst H, Westra JG, van
der Marel GA, van Boom JH: Solid-phase synthesis of DNA
fragments containing the modified base 7-hydro-8-oxo-2¢-
deoxyguanosine. Nucleic Acids Res 1991, 19:4361–4369.
59. Guy A, Duplaa A-M, Harel P, Téoule R: Synthesis and characterization
of DNA fragments bearing an adenine radiation product: 7,8-
dihydroadenin-8-one. Helvetica Chimica Acta 1988, 71:1566–1571.
60. Srivastava SC, Raza SK, Misra R: 1,N6-etheno deoxy and ribo
adenosine and 3,N4-etheno deoxy and ribo cytidine
phosphoramidites. Strongly fluorescent structures for selective
introduction in defined sequence DNA and RNA molecules. Nucleic
Acids Res 1994, 22:1296–1304.
Research Paper  Mammalian 8-oxoguanine DNA glycosylases Lu et al. 407
Because Current Biology operates a ‘Continuous Publication
System’ for Research Papers, this paper has been published
via the internet before being printed. The paper can be
accessed from http://biomednet.com/cbiology/cub — for
further information, see the explanation on the contents page.
